PACS vs SGRY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

PACS

59.8
AI Score
VS
PACS Wins

SGRY

51.8
AI Score

Investment Advisor Scores

PACS

60score
Recommendation
HOLD

SGRY

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PACS SGRY Winner
Revenue 417.37M 2.85B PACS
Net Income -17.50M 157.06M PACS
Net Margin -4.2% 5.5% PACS
Operating Income 41.20M 229.37M PACS
ROE -2.8% 14.1% PACS
ROA -0.4% 2.8% PACS
Total Assets 4.59B 5.66B PACS
Cash 112.82M 164.45M PACS
Current Ratio 1.72 0.91 SGRY

Relative Price Performance (Last 90 Days)

PACS 1M: -2.6% · 3M: -7.8% SGRY 1M: -9.4% · 3M: -23.2%

Current Technical Phase

PACS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $41.03

SGRY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $13.23

Fundamentals Snapshot

Metric PACS SGRY
Market Cap — —
Forward P/E 15.1 47.3
Trailing P/E 24.3 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 1.71 -0.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.